000			01950 a2200601 4500
005			20250514002636.0
264		0	_c20010712
008			200107s 0 0 eng d
022			_a0340-7004
024	7		_a10.1007/s002620100181 _2doi
040			_aNLM _beng _cNLM
100	1		_aParadis, T J
245	0	0	_aThe anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gamma. _h[electronic resource]
260			_bCancer immunology, immunotherapy : CII _cMay 2001
300			_a125-33 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_a2',5'-Oligoadenylate Synthetase _xmetabolism
650	0	4	_aAbatacept
650	0	4	_aAnimals
650	0	4	_aAntigens, CD
650	0	4	_aAntigens, Differentiation _xblood
650	0	4	_aApoptosis
650	0	4	_aCTLA-4 Antigen
650	0	4	_aCancer Vaccines
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFibrosarcoma _xtherapy
650	0	4	_aFlow Cytometry
650	0	4	_aImmunoconjugates
650	0	4	_aImmunoglobulin G _xmetabolism
650	0	4	_aImmunosuppressive Agents _xpharmacology
650	0	4	_aImmunotherapy
650	0	4	_aInterferon-gamma _xbiosynthesis
650	0	4	_aLymph Nodes _xcytology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMitosis
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeoplasms, Experimental _xprevention & control
650	0	4	_aPlatelet Endothelial Cell Adhesion Molecule-1 _xbiosynthesis
650	0	4	_aTime Factors
650	0	4	_aUp-Regulation
700	1		_aFloyd, E
700	1		_aBurkwit, J
700	1		_aCole, S H
700	1		_aBrunson, B
700	1		_aElliott, E
700	1		_aGilman, S
700	1		_aGladue, R P
773	0		_tCancer immunology, immunotherapy : CII _gvol. 50 _gno. 3 _gp. 125-33
856	4	0	_uhttps://doi.org/10.1007/s002620100181 _zAvailable from publisher's website
999			_c11348908 _d11348908